Orphazyme A/S (ORPH) Halted Again on LUDP, Up 137%
- Dow, S&P post worst week in months after hawkish Fed spooks investors
- Fed-fueled dollar rises as bears make for exits
- Adobe (ADBE) Edges Higher After Topping Q2 Estimates, Analysts Raise PT on 'Impressive' Performance
- Fed Statement Very Bullish for Tech Stocks, Focus on Cloud and Cyber Stocks - Wedbush
- You Fight Real Physical Inflation With Rate Hikes, Not Talk of Rate Hikes; Buy the Dip in Commodities, Gold Underpriced - Goldman Sachs
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - June 10, 2021 11:47 AM EDT)
Orphazyme A/S (NASDAQ: ORPH) Halted Again on LUDP, Up 137%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orphazyme A/S (ORPH) Sinks 54% on CRL
- Acorda Therapeutics (ACOR) Gains 10% Following Upgrade to Buy
- Lordstown Motors (RIDE) Falls 7% After Saying it Has No Binding Orders
Create E-mail Alert Related CategoriesMomentum Movers, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!